-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.00259.71% Upside
Compass Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Compass Therapeutics, Inc.?
Compass Therapeutics, Inc. has been rated by research analysts at Compass Point in the past 90 days.